当前位置: 首页 > 医学版 > 期刊论文 > 基础医学 > 感染与免疫杂志 > 2005年 > 第11期 > 正文
编号:11254379
Effects of Anaplasma phagocytophilum on Host Cell Ferritin mRNA and Protein Levels
     Department of Microbiology, Immunology, and Molecular Genetics, University of Kentucky College of Medicine, Lexington, Kentucky

    Sections of Immunobiology

    Rheumatology, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut

    ABSTRACT

    Ferritin is a major intracellular iron storage protein and also functions as a cytoprotectant by sequestering iron to minimize the formation of reactive oxygen species. Anaplasma phagocytophilum, the causative agent of human granulocytic anaplasmosis, is an obligate intracellular bacterium that colonizes neutrophils. We have previously reported that human promyelocytic HL-60 cells infected with A. phagocytophilum demonstrate increased transcription of ferritin heavy chain and also that the bacterium stimulates neutrophil NADPH oxidase assembly and degranulation during the initial hours of infection (J. A. Carlyon, W. T. Chan, J. Galan, D. Roos, and E. Fikrig, J. Immunol. 169:7009-7018, 2002, and J. A. Carlyon, D. Abdel-Latif, M. Pypaert, P. Lacy, and E. Fikrig, Infect. Immun. 72:4772-4783, 2004). In this study, we assessed ferritin mRNA and protein levels during A. phagocytophilum infection in vitro using HL-60 cells and neutrophils and in vivo using neutrophils from infected mice. The addition of A. phagocytophilum, as well as Escherichia coli and serum-opsonized zymosan, to neutrophils results in a pronounced increase in ferritin light-chain transcription and a concomitant rise in ferritin protein levels. Neutrophils from A. phagocytophilum-infected mice demonstrate elevated ferritin heavy-chain mRNA expression, a phenomenon consistent with infections by intracellular pathogens. Notably, ferritin protein levels of infected HL-60 cells were markedly diminished in a dose- and time-dependent manner. These studies provide insight into the effects A. phagocytophilum has on the ferritin levels of its host cell.

    INTRODUCTION

    Anaplasma phagocytophilum is the etiologic agent of human granulocytic anaplasmosis, an emerging disease that is gaining increased recognition in the United States, Europe, and Asia. A. phagocytophilum is an obligate intracellular bacterium that naturally exists in a zoonotic cycle between ticks of the Ixodes persulcatus complex and small mammals. Humans are accidental hosts. The bacterium resides within the salivary glands of its arthropod vector and, following inoculation into a mammalian host, preferentially colonizes neutrophils or neutrophil precursors (15, 16, 19). Nonspecific symptoms associated with human granulocytic anaplasmosis include fever, chills, headache, malaise, and myalgia. More distinguishing manifestations consist of leukopenia, thrombocytopenia, and elevated levels of C- reactive protein and hepatic transaminases. Though usually self-limiting, severe complications can result and include prolonged fever, shock, seizures, pneumonitis, acute renal failure, hemorrhages, rhabdomyolysis, and death (3, 15-17).

    Bacterial pathogens can freely acquire necessary nutrients from their hosts, except for iron, which is essential for the growth of nearly all bacterial species (37, 45). The concentration of free iron in mammals, however, is exceptionally low, because it is sequestered by iron-withholding proteins. Maintenance of proper intracellular iron levels involves its uptake, utilization, and storage. Extracellular iron is bound by transferrin, which docks to its receptor, is endocytosed, and releases the iron before recycling back to the cell surface (24, 42). The delivered iron becomes part of the labile iron pool (LIP), which can either be used immediately for metabolic processes or stored (23, 47, 49). It is crucial that proper iron homeostasis be maintained, as excess iron provides a source for the growth of intracellular bacteria (37, 42). Furthermore, excess levels promote formation of cytotoxic reactive oxygen species (ROS). Excess iron from the LIP can participate in the Fenton reaction [Fe(II) + H2O2 Fe(III) + OH– + OH], which yields a hydroxyl radical, the most potent oxidant in biological systems (47). The toxicity of iron is largely attributable to its capacity to generate such reactive species.

    Ferritin is the major intracellular iron storage protein of prokaryotes and eukaryotes (23, 47). Mammalian ferritin is a 24-mer protein composed of various proportions of heavy (H) and light (L) subunits and has an extremely high storage capacity of up to 4,500 iron atoms. Steps in iron storage within ferritin molecules consist of Fe(II) oxidation, Fe(III) migration, and iron core formation. H chains are important for Fe(II) oxidation, while L chains assist in core formation (23). Ferritin molecules with greater proportions (67 to 83%) of ferritin light chains (FLC) are most efficient at incorporating and storing iron (23, 47). By removing excess iron from the LIP, ferritin also serves as a cytoprotectant against ROS- mediated damage (4, 11, 21, 26, 30-32, 39, 50). Indeed, ferritin levels increase as a direct response to oxidative stress. Other factors that regulate ferritin expression include intracellular iron concentration, gamma interferon (IFN-), proinflammatory cytokines, growth factors, and differentiation (47).

    We have previously shown that A. phagocytophilum infection of HL-60 cells and all-trans retinoic acid-differentiated HL-60 (rHL-60) cells results in an up-regulation of ferritin H-chain (fhc) mRNA expression (14). The influence of A. phagocytophilum on flc transcription and ferritin protein levels is unknown. We have also demonstrated that A. phagocytophilum binding and invasion of neutrophils in vitro stimulates NADPH oxidase assembly and degranulation, two processes that result in ROS release (12). Because ferritin could serve as an intracellular source of iron for A. phagocytophilum and because ferritin functions as a major cytoprotectant against oxidative stress, we further investigated the effects of A. phagocytophilum on ferritin mRNA and protein expression in HL-60 cells and human neutrophils during in vitro infection and in murine neutrophils during in vivo infection. These studies shed light onto the influence of A. phagocytophilum on the ferritin levels of its mammalian host cell.

    MATERIALS AND METHODS

    Cultivation of A. phagocytophilum and maintenance of infection. A. phagocytophilum strains NCH-1 and HZ were cultivated in HL-60 cells as previously described (14). Strain HZ was kindly provided by Ralph Horowitz of New York Medical College (Valhalla) and Yasuko Rikihisa of Ohio State University (Columbus). A. phagocytophilum infection was initiated in vivo by inoculating inbred C3H-scid mice with A. phagocytophilum-infected HL-60 cells. Infection was maintained in C3H-scid mice by inoculating nave mice with 100 μl of A. phagocytophilum-infected C3H-scid mouse blood every 4 to 6 weeks.

    Isolation of human neutrophils. Human neutrophils were isolated from peripheral blood from healthy donors by centrifugation through an equal volume of Polymorphprep (Axis-Shield; Greiner Bio-One, Frickenhausen, Germany) at 470 x g for 30 min. The resulting neutrophil band was removed by aspiration and mixed with equal volumes of 0.45% NaCl and Iscove's modified Dulbecco's medium (IMDM; Invitrogen, Carlsbad, CA)-0.5 mM EDTA to restore isotonic conditions. The cells were centrifuged at 210 x g for 10 min, and the supernatant was removed. The resulting pellet was resuspended and incubated in 10 ml of red blood cell lysing buffer (Sigma, St. Louis, Mo.) for 10 min followed by two successive washes in IMDM-0.5 mM EDTA and enumeration using a hemacytometer.

    In vitro A. phagocytophilum infection. Host-cell-free A. phagocytophilum cells were recovered from infected HL-60 cells and added to 5 x 106 HL-60 cells (0.5 x 105/ml) in IMDM-10% fetal bovine serum. The ratios of A. phagocytophilum organisms per HL-60 cell were determined as described previously (12). For in vitro infection of human neutrophils, 5 x 105 neutrophils (1 x 106/ml) in IMDM were added to individual wells of either 6- or 24-well Ultra Low Attachment plates (Corning, Inc.; Corning, NY). To these were added suspensions of host-cell-free A. phagocytophilum. In some cases, zymosan A particles from Saccharomyces cerevisiae (Sigma) that had been opsonized with autologous serum (OpZ) or Escherichia coli were added to neutrophils as previously described (12). At 1, 3, and 6 h postinfection, either total RNA or protein was isolated as described below.

    RNA isolation and reverse transcription-PCR (RT-PCR). Total RNA from uninfected or A. phagocytophilum-infected cells was isolated using Trizol (Invitrogen) according to the manufacturer's instructions followed by treatment with RNase-free DNase (1 U/500 μg; Roche Molecular Biochemicals, Indianapolis, IN) for 2 h at 37°C. DNA-free RNA was reextracted using Trizol, ethanol precipitated, and resuspended in diethyl pyrocarbonate-treated water. cDNA stocks (50 μl) were prepared from 5 μg of total RNA using random hexamers and the ProSTAR First Strand RT-PCR kit (Stratagene, La Jolla, CA), followed by PCR amplification using 1 μl of cDNA template. The thermal cycling conditions used were 94°C for 2 min followed by 35 cycles of 94°C for 60 s, 55°C for 60 s, 72°C for 60 s, and a final extension step of 72°C for 7 min. The reaction mixture contained final concentrations of 1.5 mM MgCl2, 200 μM deoxynucleoside triphosphates, 0.8 μM of each primer, and 2.5 U of Taq polymerase (Roche Molecular Biochemicals). To ensure that RNA templates were free from contaminating DNA, identical reactions were performed in the absence of reverse transcriptase (data not shown). The primers used are listed in Table 1.

    Quantitative RT-PCR. cDNAs generated from uninfected and A. phagocytophilum-infected cells were used as templates for quantitative PCR using the MyiQ Real Time Detection System (Bio-Rad, Richmond, CA). Each cDNA was in a reaction mixture that contained final concentrations of 1.5 U platinum Taq DNA polymerase (Life Technologies, Gaithersburg, MD), 20 mM Tris-HCl (pH 8.4), 50 mM KCl, 3 mM MgCl2, 200 μM deoxynucleoside triphosphates, 500 nM of each primer, and 300 nM TaqMan probe targeting either fhc or flc. The sequences of the TaqMan probes are listed in Table 1. The probes were labeled at their 5' ends with 6-carboxyfluorescein and at their 3' ends with carboxytetramethylrhodamine. Thermal cycling conditions, fluorescence detection, and quantification were performed as previously described (14), except that starting quantities were extrapolated in copy numbers instead of nanograms. -actin gene expression was determined using the TaqMan -actin Control kit (Perkin Elmer, Foster City, CA) according to the manufacturer's instructions.

    Immunoblot analyses. Whole-cell lysates of uninfected or A. phagocytophilum-infected cells were prepared, quantified, fractionated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and transferred to Immobilon-P membranes (Millipore, Bedford, MA) as described previously (14). Human actin and A. phagocytophilum P44 were detected using mouse anti-human actin MAb (Sigma) and rabbit polyclonal anti-A. phagocytophilum serum, respectively, followed by goat anti-rabbit immunoglobulin G-Alexa Fluor 680 (Molecular Probes, Eugene, OR) and goat anti-mouse immunoglobulin G-IRDYE800CW (Rockland Immunochemicals, Gilbertsville, PA), respectively. Bound antibodies were detected using the Odyssey Infrared Imager (LI-COR Biosciences, Lincoln, NE).

    Ferritin enzyme-linked immunosorbent assay (ELISA). Whole-cell lysates were examined for ferritin content using the Human Ferritin ELISA kit (Alpha Diagnostic, San Antonio, TX) according to the manufacturer's instructions. Briefly, 30 μg of whole-cell lysate, 30 μg bovine serum albumin (BSA), or 10 μl of recombinant ferritin standards, ranging from 0 to 800 ng/ml, were added in duplicate to wells of a 96-well plate coated with anti-ferritin MAb. One-hundred microliters of horseradish peroxidase-conjugated anti-ferritin MAb were added, followed by a 30-min incubation at room temperature. The plate was washed three times with 300 μl deionized water, followed by the addition of 200 μl detection substrate per well. After 10 min, 50 μl stop solution was added and the absorbance at 450 nm was recorded using an AD 340 Absorbance Detector (Beckman Coulter, Fullerton, CA).

    Assessment of fhc and flc mRNA expression during murine A. phagocytophilum infection. Infected blood from C3H-scid mice was used to initiate infection in immunocompetent C3H/HeN mice (3 per group) as previously reported (13). Nine percent of peripheral blood neutrophils in the inoculum had detectable morulae. Control groups were injected with uninfected C3H-scid mouse blood. On days 2 and 8, the respective groups were sacrificed and assessed for bacterial burden by determining the percentage of morulae-positive neutrophils using light microscopy and by PCR. Neutrophils were isolated from pooled splenocytes via positive selection using fluorescein isothiocyanate-conjugated rat anti-mouse Ly6G (Gr-1; a neutrophil-specific marker) MAb (BD Pharmingen, San Diego, CA) followed by anti-fluorescein isothiocyanate MAb conjugated to magnetic beads (Miltenyi Biotec, Auburn, CA). Total RNA was isolated from Gr-1-positive and -negative cells as described above and used as template for RT-PCR.

    Statistical analyses. Statistical analyses were performed using the Prism 4.0 software package (Graphpad, San Diego, CA). If one-way analysis of variance (ANOVA) or two-way ANOVA indicated a group difference (P < 0.05), then Tukey's or Bonferroni's test was used, respectively, to test for a significant difference among groups. In some instances, the means for uninfected and infected samples per time point were examined using the Student t test.

    Study approval. The Human Investigation Committees at Yale University and the University of Kentucky and the Yale University Institutional Animal Care and Use Committee approved these studies.

    RESULTS

    HL-60 cell fhc mRNA levels increase after a minimum of 24 h of A. phagocytophilum infection. We have previously reported that HL-60 and rHL-60 cells with established A. phagocytophilum infections exhibit increased fhc mRNA levels (14). However, neither the kinetics of fhc transcription immediately following A. phagocytophilum infection nor the effects of the bacterium on flc expression are known. We therefore added host-cell-free A. phagocytophilum (10 organisms per cell) to HL-60 cells, isolated total RNA, and performed quantitative RT-PCR (QRT-PCR) to assess changes in fhc and flc expression over 96 h of infection. For all samples, flc mRNA levels exceeded those of fhc by as much as 57.0- to 297.1-fold (Fig. 1). For the initial 12 h of infection, fhc mRNA levels of A. phagocytophilum-infected cells were 1.2- to 1.7-fold lower than those of uninfected control cells. Consistent with our previous study (14), however, fhc expression by A. phagocytophilum-infected cells increased significantly above those of uninfected controls by 24 h postinfection (hpi) and remained so throughout the duration of the time course. The largest rise in fhc message, a 2.6-fold increase, was observed at 96 hpi. With the exception of 30 min postinfection, little to no change was observed in flc transcription between infected and uninfected control HL-60 cells. These data demonstrate that the increased fhc mRNA levels associated with A. phagocytophilum infection of HL-60 cells are not observable until at least 24 hpi.

    Ferritin protein levels in HL-60 cells decrease in a dose- and time-dependent manner following A. phagocytophilum infection. Though transcriptional expression does play a role in modulating ferritin levels within eukaryotic cells, ferritin homeostasis is primarily regulated at the level of protein translation (23, 24). We therefore investigated changes in ferritin content in HL-60 cells following A. phagocytophilum infection. Host-cell-free A. phagocytophilum organisms were added to HL-60 cells at approximate ratios of 0, 0.4, 1.1, 3.3, and 10 bacteria per cell. Four days postinfection, whole-cell lysates were extracted and analyzed. Samples exhibited no difference in actin levels upon immunoblot analysis, thereby demonstrating they were effectively normalized (Fig. 2A). As expected, a dose-dependent increase in A. phagocytophilum P44 was observed. When examined by ELISA, ferritin protein levels decreased in a dose-dependent manner in response to A. phagocytophilum burden (Fig. 2B). HL-60 cells that were inoculated with 10 organisms per cell demonstrated a threefold decline in ferritin levels at 96 hpi. This decline was maximal, as cultures that were inoculated with 30 bacteria per cell exhibited nearly identical decreases (data not shown). To assess the effect of A. phagocytophilum on HL-60 cell ferritin protein expression at earlier time points, host-cell-free bacteria were added at approximate ratios of 0, 1, and 10 per cell, and the time course was repeated. At 24, 48, and 96 hpi, whole-cell lysates were assessed for ferritin content. While ferritin levels increased per respective samples over the duration of the time course, A. phagocytophilum-infected cells exhibited a dose-dependent decrease in ferritin relative to uninfected controls (Fig. 2C). Significant decreases in ferritin levels were apparent for cells inoculated with 10 organisms per cell as early as 24 hpi, which demonstrated a 1.7-fold reduction. A significant decrease in ferritin expression for cells inoculated with 1 bacterium per cell was not evident until 96 hpi. The reduction in ferritin levels in infected HL-60 cells relative to uninfected controls is apparent as early as 30 min postinfection and continues throughout the initial hours of A. phagocytophilum infection (Fig. 2D). However, the differences in ferritin levels between infected and uninfected controls are not statistically significant until 24 to 48 hpi. The observed changes in ferritin levels are not in response to fluctuations in whole-cell iron concentrations, which remained at levels that were too low to be detected by the ferrozine binding assay (43) throughout the time courses (data not shown). Thus, these results demonstrate that A. phagocytophilum infection of HL-60 cells results in a bacterial dose- and time-dependent reduction in host cell ferritin levels.

    Human neutrophil flc levels rapidly increase in response to A. phagocytophilum infection in vitro. The effects of A. phagocytophilum on ferritin transcription in neutrophils are unknown. Furthermore, while the promyelocytic HL-60 cell line is permissive to A. phagocytophilum, it does not accurately mimic the natural mammalian host cell for the bacterium. For instance, HL-60 cells are devoid of specific granules and are unable to generate a robust respiratory burst compared to neutrophils. We and others have previously demonstrated that following binding to the neutrophil surface in vitro, A. phagocytophilum internalization is a prolonged process that lasts for several hours (8, 12, 25). This prolonged association of the bacterium with the neutrophil outer membrane stimulates at least some degree of NADPH oxidase assembly and degranulation (12). Because of ferritin's role as a cytoprotectant against oxidative damage and to better understand the neutrophil expression profile in response to intracellular infection, we investigated changes in fhc and flc mRNA levels in neutrophils during the early hours of A. phagocytophilum infection. Human neutrophils were incubated in the presence and absence of host-cell-free A. phagocytophilum at an approximate ratio of 10 organisms per cell. The kinetics of infection paralleled previous observations (12) and achieved a maximum of 90% infected neutrophils by 6 h postaddition of bacteria (data not shown). At 1, 3, and 6 hpi, total RNA was extracted and subjected to RT-PCR. Samples were normalized to -actin expression. In contrast to that observed during the initial hours of infection in HL-60 cells, neutrophils incubated with A. phagocytophilum demonstrated successive rises in not only fhc transcription but also flc transcription throughout the course of infection (Fig. 3A).

    To further define the relevance of the observed changes in ferritin transcription associated with A. phagocytophilum infection, the time course was repeated with neutrophils being incubated with host-cell-free A. phagocytophilum, Escherichia coli, or OpZ. The latter two stimuli served as controls for activating neutrophil NADPH oxidase and degranulation. Changes in fhc and flc expression were quantified using QRT-PCR. Similar to that observed for HL-60 cells, flc levels exceeded fhc levels by as much as 20.6-fold (Fig. 3B). Consistent with the semiquantitative RT-PCR studies, A. phagocytophilum infection stimulated a twofold, statistically insignificant rise in fhc expression. Neutrophils incubated with E. coli, however, demonstrated as much as a 12.8-fold increase in fhc transcript levels. Incubation with OpZ yielded as much as a 3.2-fold rise in fhc message, though this change was not significant. In contrast to that observed for neutrophil fhc mRNA levels, flc transcription significantly increased following incubation with A. phagocytophilum, with increases of 16.2-, 20.0-, and 62.9-fold relative to uninfected controls at 1, 3, and 6 hpi, respectively. Ferritin light-chain expression also significantly increased in response to E. coli and OpZ. Thus, ferritin expression, particularly that of flc, rapidly increases during the initial hours of A. phagocytophilum infection and upon exposure to phagocytic stimuli such as E. coli and OpZ.

    Neutrophil ferritin protein levels increase during the initial hours of A. phagocytophilum infection in vitro. Neutrophil fhc transcription exhibits a low level of increase, while flc mRNA expression increases dramatically during the initial hours of A. phagocytophilum infection. Similar transcriptional profiles were also observed upon incubating neutrophils with E. coli and OpZ. We therefore examined whether the observed increases in ferritin transcription in neutrophils translates to rises in ferritin protein levels following incubation with each of these stimuli. Host-cell-free A. phagocytophilum, E. coli, or OpZ was added to neutrophils, after which whole-cell lysates were examined for ferritin content at 1, 3, and 6 hpi. At 1 hpi, neutrophil ferritin levels exhibited a three- to fourfold increase for all stimuli relative to uninfected controls (Fig. 4). Ferritin levels of A. phagocytophilum-infected cells remained high throughout the time course, while those of cells exposed to E. coli had declined to levels that were not significantly different from those of uninfected controls by 3 hpi. Ferritin expression by neutrophils exposed to OpZ had also dropped considerably at 3 and 6 hpi. Thus, exposure of neutrophils to A. phagocytophilum results in a sustained rise in ferritin levels, while exposure to either E. coli or OpZ stimulates an initially pronounced spike followed by a subsidence in ferritin amounts. The kinetics of ferritin expression induced by A. phagocytophilum, E. coli, and OpZ parallel the effects each of these stimuli has on NADPH oxidase assembly and degranulation in vitro (14). These data are consistent with the induction of ferritin expression as a cytoprotective response to ROS.

    Changes in fhc and flc expression during murine A. phagocytophilum infection. To extend our analyses in vivo, C3H/HeJ mice were inoculated with A. phagocytophilum. Sham-inoculated mice served as controls. On days 2 and 8, the respective groups were sacrificed and assessed for bacterial burden by determining the percentage of morulae-positive neutrophils using light microscopy and PCR. On days 2 and 8, the percentages of neutrophils with detectable morulae were 1.5% ± 1.1% and 7.9% ± 2.6%, respectively (data not shown). Neutrophils were isolated from pooled splenocytes via positive selection. Total RNA was isolated from Gr-1-positive (neutrophils) and Gr-1-negative (nonneutrophil splenocytes) cells and used as template for RT-PCR. No differences in fhc or flc mRNA levels were apparent in Gr-1-negative cells from infected and uninfected mice on either day (Fig. 5). Consistent with observations for uninfected HL-60 cells and human neutrophils, murine neutrophils (GR-1-positive splenocytes) exhibited strong flc expression. By days 2 and 8 postinfection, however, flc expression had dropped considerably for Gr-1-positive cells. There was no detectable difference in fhc expression between neutrophils from infected and uninfected mice on day 2. Notably, though, fhc transcription was strongly up-regulated in neutrophils from infected mice on day 8, which typically corresponds to peak infection. These profiles are highly consistent with what would be expected to occur in the context of a strong IFN- response (47), which is a common manifestation of A. phagocytophilum infection (2, 20, 33). Thus, in vivo A. phagocytophilum infection results in a pronounced increase in neutrophil fhc expression, a pattern that is consistent with the IFN--dominated cytokine profile associated with infections by obligate intracellular pathogens.

    DISCUSSION

    A major function of ferritin is to limit Fe(II) available to participate in the generation of ROS. Oxidative stress activates transcriptional and posttranscriptional pathways of ferritin regulation (47). For instance, oxidants have been shown to increase fhc and flc expression in liver cell lines (48). Additionally, transcriptional induction of fhc and flc occurs in rat liver following injection with phorone, which inhibits free radical defense mechanisms by reducing glutathione concentration (11). Furthermore, eukaryotic cells enriched for ferritin H or ferritin L levels by either transfection (21, 36, 40) or pinocytosis (29) demonstrate a reduced LIP and, consequently, enhanced resistance to H2O2-induced oxidative damage. Conversely, cells in which fhc expression is down-regulated via an antisense oligonucleotide are more susceptible to oxidative insult (29).

    As such, ferritin expression during the initial hours of A. phagocytophilum infection in vitro likely occurs as a response to ROS production during bacterial binding and invasion. Neutrophil transcription of ferritin heavy and light subunits is induced by as much as 12.8- and 62.9-fold, respectively, following exposure to A. phagocytophilum, E. coli, or OpZ, with a concomitant three- to fourfold rise in ferritin protein levels. The elevated protein levels in response to A. phagocytophilum are maintained throughout the course of infection, while those in response to E. coli and OpZ subside. The initial spike and subsidence of ferritin expression in response to E. coli and OpZ are consistent with the kinetics of ROS production associated with phagocytosis of each of these stimuli (12). Similarly, the maintained elevation in neutrophil ferritin content throughout the initial hours of A. phagocytophilum infection is consistent with a sustained, low-level stimulation of NADPH oxidase. We have previously demonstrated that internalization of A. phagocytophilum in vitro occurs over several hours following bacterial binding to neutrophil surfaces and that this process is associated with some degree of host cell activation, NADPH oxidase mobilization, and degranulation (12). Furthermore, A. phagocytophilum infection also stimulates neutrophil transcription of superoxide dismutase, which further evidences the induction of a cytoprotective response (8, 38).

    The rises in ferritin content observed for neutrophils upon exposure to A. phagocytophilum were not noted for HL-60 cells. This is likely because promyelocytic HL-60 cells lack specific granules and express low levels of NADPH oxidase components compared to mature neutrophils (1, 7, 46). Consequently, stimulation of HL-60 cells elicits O2– at levels that are orders of magnitude lower than those observed upon neutrophil stimulation. As such, the addition of A. phagocytophilum to HL-60 cells yields little ROS production relative to that observed for neutrophils (5, 12).

    The induction of fhc expression in neutrophils over 6 h of A. phagocytophilum infection in vitro is minor compared to the considerable increase in fhc message observed on day 8 of in vivo infection. It is well established that IFN- plays a major role in host defense against intracellular pathogens. Accordingly, IFN- dominates the host cytokine response to A. phagocytophilum infection, with the highest levels being produced between days 5 and 10 (2, 20). It has been demonstrated that incubation of THP-1 cells in the presence of IFN- strongly up-regulates fhc mRNA expression with a concomitant increase in ferritin protein (44). Given the influence of IFN- on fhc expression, it is not surprising that the ferritin transcription profile of the entire neutrophil population of A. phagocytophilum-infected mice at the peak of bacteremia displays a pronounced shift from flc to fhc.

    HL-60 cells demonstrate a marked increase in fhc mRNA synthesis during the course of A. phagocytophilum infection, as confirmed by cDNA microarray screening (14) as well as semiquantitative and QRT-PCR. A similar result was noted for THP-1 cells infected with Mycobacterium bovis BCG (28). Thus, an increase in fhc expression may exemplify a common theme among host expression profiles associated with intracellular bacterial infection.

    Current knowledge supports that, with the exception of Borrelia burgdorferi (41), all pathogenic bacteria require iron as a metabolic cofactor (37). The mechanism by which A. phagocytophilum obtains iron from its host cell or whether acquiring iron is necessary for this bacterium's survival is unknown. Barnewall and colleagues demonstrated that Ehrlichia chaffeensis and E. sennetsu, but not A. phagocytophilum, exploit the transferrin receptor pathway as a means for obtaining iron that is brought into the host cell before it can be utilized for host metabolic processes or stored by ferritin (6, 34). Within 30 min of A. phagocytophilum infection, HL-60 cell ferritin protein levels are lowered relative to uninfected controls, though the reduction is not statistically significant until at least 24 hpi. Given the slow doubling time of A. phagocytophilum (9), it is not surprising that the decline in ferritin content relative to uninfected cells does not become significant until this time point, as this effect is bacterial dose dependent. Ferritin light-subunit mRNA expression exhibits little to no change for infected HL-60 cells at all time points, while fhc mRNA levels are significantly elevated at 24, 48, and 96 hpi. Thus, the loss of ferritin protein is not a consequence of transcriptional inhibition. This suggests the possibility that A. phagocytophilum may either degrade or promote the degradation of ferritin protein, which would release iron for use by the bacterium. Support for this speculation is offered by the recent report by Larson and colleagues that Neisseria meningitidis accelerates degradation of ferritin within A431 epithelial cells to yield a useable iron source (27). As observed for A. phagocytophilum-infected HL-60 cells, fhc and flc mRNA levels of N. meningitidis-infected epithelial cells remain relatively unchanged while ferritin protein levels are significantly reduced over the course of infection. This may represent a common theme among intracellular pathogens, as Legionella pneumophila (10, 22), Mycobacterium tuberculosis (35), and Listeria monocytogenes (45) have also been shown to access intracellular iron stores by undefined mechanisms.

    While a mechanism for Fe(III) release via host cell ferritin degradation has been documented for N. meningitidis, a corresponding neisserial iron binding protein has yet to be identified. Doyle and colleagues recently identified a ferric ion-binding protein (FBP) homolog in Ehrlichia canis and E. chaffeensis (18). Putting this information into context with data presented in this report and by Larson et al. (27), it is tempting to surmise whether A. phagocytophilum also expresses an FBP homolog and whether it plays a role in acquiring Fe(III) released from degraded ferritin.

    These studies provide insight into the effects A. phagocytophilum has on the ferritin levels of its mammalian host at different stages of infection. The potential role of ferritin degradation by A. phagocytophilum as a means for obtaining iron and whether an Ehrlichia-like FBP is involved in this process represent exciting areas for further investigation.

    ACKNOWLEDGMENTS

    We thank Ralph Horowitz of New York Medical College and Yasuko Rikihisa of Ohio State University for providing A. phagocytophilum strain HZ and Jennifer Marcum for technical assistance.

    This work was supported by grants KO1DK065039 (J.A.C.), P20 RR20171 (J.A.C.), and AI041440 (E.F.) from the National Institutes of Health and the Burroughs Wellcome Fund (E.F.).

    REFERENCES

    1. Ahmed, N., J. F. Williams, and M. J. Weidemann. 1991. The human promyelocytic HL60 cell line: a model of myeloid cell differentiation using dimethylsulphoxide, phorbol ester and butyrate. Biochem. Int. 23:591-602.

    2. Akkoyunlu, M., and E. Fikrig. 2000. Gamma interferon dominates the murine cytokine response to the agent of human granulocytic ehrlichiosis and helps to control the degree of early rickettsemia. Infect. Immun. 68: 1827-1833.

    3. Bakken, J. S., J. S. Dumler, S. M. Chen, M. R. Eckman, L. L. Van Etta, and D. H. Walker. 1994. Human granulocytic ehrlichiosis in the upper midwest United States. A new species emerging JAMA 272:212-218.

    4. Balla, G., H. S. Jacob, J. Balla, M. Rosenberg, K. Nath, F. Apple, J. W. Eaton, and G. M. Vercellotti. 1992. Ferritin: a cytoprotective antioxidant strategem of endothelium. J. Biol. Chem. 267:18148-18153.

    5. Banerjee, R., J. Anguita, D. Roos, and E. Fikrig. 2000. Infection by the agent of human granulocytic ehrlichiosis prevents the respiratory burst by down-regulating gp91phox. J. Immunol. 164:3946-3949.

    6. Barnewall, R. E., N. Ohashi, and Y. Rikihisa. 1999. Ehrlichia chaffeensis and E. sennetsu, but not the human granulocytic ehrlichiosis agent, colocalize with transferrin receptor and up-regulate transferrin receptor mRNA by activating iron-responsive protein 1. Infect. Immun. 67:2258-2265.

    7. Birnie, G. D. 1988. The HL60 cell line: a model system for studying human myeloid cell differentiation. Br. J. Cancer 9(Suppl.):41-45.

    8. Borjesson, D. L., S. D. Kobayashi, A. R. Whitney, J. M. Voyich, C. M. Argue, and F. R. Deleo. 2005. Insights into pathogen immune evasion mechanisms: Anaplasma phagocytophilum fails to induce an apoptosis differentiation program in human neutrophils. J. Immunol. 174:6364-6372.

    9. Branger, S., J. M. Rolain, and D. Raoult. 2004. Evaluation of antibiotic susceptibilities of Ehrlichia canis, Ehrlichia chaffeensis, and Anaplasma phagocytophilum by real-time PCR. Antimicrob. Agents Chemother. 48:4822-4828.

    10. Byrd, T. F., and M. A. Horwitz. 1991. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J. Clin. Investig. 88:351-357.

    11. Cairo, G., L. Tacchini, G. Pogliaghi, E. Anzon, A. Tomasi, and A. Bernelli-Zazzera. 1995. Induction of ferritin synthesis by oxidative stress. Transcriptional and post-transcriptional regulation by expansion of the "free" iron pool. J. Biol. Chem. 270:700-703.

    12. Carlyon, J. A., D. Abdel-Latif, M. Pypaert, P. Lacy, and E. Fikrig. 2004. Anaplasma phagocytophilum utilizes multiple host evasion mechanisms to thwart NADPH oxidase-mediated killing during neutrophil infection. Infect. Immun. 72:4772-4783.

    13. Carlyon, J. A., M. Akkoyunlu, L. Xia, T. Yago, T. Wang, R. D. Cummings, R. P. McEver, and E. Fikrig. 2003. Murine neutrophils require alpha 1,3-fucosylation but not PSGL-1 for productive infection with Anaplasma phagocytophilum. Blood 102:3387-3395.

    14. Carlyon, J. A., W. T. Chan, J. Galan, D. Roos, and E. Fikrig. 2002. Repression of rac2 mRNA expression by Anaplasma phagocytophila is essential to the inhibition of superoxide production and bacterial proliferation. J. Immunol. 169:7009-7018.

    15. Carlyon, J. A., and E. Fikrig. 2003. Invasion and survival strategies of Anaplasma phagocytophilum. Cell Microbiol. 5:743-754.

    16. Carlyon, J. A., and E. Fikrig. 2004. Pathogenic strategies of Anaplasma phagocytophilum, a unique bacterium that colonizes neutrophils, p. 301-329. In M. Scourfield (ed.), 63rd Symposium of the Society for General Microbiology. Cambridge University Press, University of Bath, Bath, United Kingdom.

    17. Chen, S. M., J. S. Dumler, J. S. Bakken, and D. H. Walker. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595.

    18. Doyle, C. K., X. Zhang, V. L. Popov, and J. W. McBride. 2005. An immunoreactive 38-kilodalton protein of Ehrlichia canis shares structural homology and iron-binding capacity with the ferric ion-binding protein family. Infect. Immun. 73:62-69.

    19. Dumler, J. S., and J. S. Bakken. 1998. Human ehrlichioses: newly recognized infections transmitted by ticks. Annu. Rev. Med. 49:201-213.

    20. Dumler, J. S., E. R. Trigiani, J. S. Bakken, M. E. Aguero-Rosenfeld, and G. P. Wormser. 2000. Serum cytokine responses during acute human granulocytic ehrlichiosis. Clin. Diagn. Lab. Immunol. 7:6-8.

    21. Epsztejn, S., H. Glickstein, V. Picard, I. N. Slotki, W. Breuer, C. Beaumont, and Z. I. Cabantchik. 1999. H-ferritin subunit overexpression in erythroid cells reduces the oxidative stress response and induces multidrug resistance properties. Blood 94:3593-3603.

    22. Gebran, S. J., C. Newton, Y. Yamamoto, R. Widen, T. W. Klein, and H. Friedman. 1994. Macrophage permissiveness for Legionella pneumophila growth modulated by iron. Infect. Immun. 62:564-568.

    23. Harrison, P. M., and P. Arosio. 1996. The ferritins: molecular properties, iron storage function and cellular regulation. Biochim. Biophys. Acta 1275:161-203.

    24. Hentze, M. W., M. U. Muckenthaler, and N. C. Andrews. 2004. Balancing acts: molecular control of mammalian iron metabolism. Cell 117:285-297.

    25. Ijdo, J., and A. C. Mueller. 2004. Neutrophil NADPH oxidase is reduced at the Anaplasma phagocytophilum phagosome. Infect. Immun. 72:5392-5401.

    26. Kakhlon, O., Y. Gruenbaum, and Z. I. Cabantchik. 2001. Repression of ferritin expression increases the labile iron pool, oxidative stress, and short-term growth of human erythroleukemia cells. Blood 97:2863-2871.

    27. Larson, J. A., H. L. Howie, and M. So. 2004. Neisseria meningitidis accelerates ferritin degradation in host epithelial cells to yield an essential iron source. Mol. Microbiol. 53:807-820.

    28. Lim, J. S., S. H. Lee, E. Lee, Y. Kang, J. W. Kim, J. K. Kim, H. H. Kim, C. Lee, S. J. Kim, G. H. Bai, H. G. Lee, K. D. Kim, T. W. Chung, and Y. K. Choe. 1997. Differential expression of ferritin heavy chain in THP-1 cells infected with Mycobacterium bovis BCG. Biochem. Mol. Biol. Int. 43:981-988.

    29. Lin, F., and A. W. Girotti. 1998. Hemin-enhanced resistance of human leukemia cells to oxidative killing: antisense determination of ferritin involvement. Arch. Biochem. Biophys. 352:51-58.

    30. Lipinski, P., J. C. Drapier, L. Oliveira, H. Retmanska, B. Sochanowicz, and M. Kruszewski. 2000. Intracellular iron status as a hallmark of mammalian cell susceptibility to oxidative stress: a study of L5178Y mouse lymphoma cell lines differentially sensitive to H(2)O(2). Blood 95:2960-2966.

    31. Lipinski, P., and H. Retmanska. 1995. Ferritin protects mice against phorbol 12-myristate 13-acetate (PMA)-induced oxidative stress in vivo. Abstr. Int. Conf. Bioiron 180, Asheville, N.C., 16 to 21 April, 1995.

    32. Lipinski, P., and H. Retmanska. 1996. Horse spleen ferritin inhibits superoxide production by equine blood monocytes in vitro. Free Radic. Biol. Med. 20:729-734.

    33. Martin, M. E., J. E. Bunnell, and J. S. Dumler. 2000. Pathology, immunohistology, and cytokine responses in early phases of human granulocytic ehrlichiosis in a murine model. J. Infect. Dis. 181:374-378.

    34. Mott, J., R. E. Barnewall, and Y. Rikihisa. 1999. Human granulocytic ehrlichiosis agent and Ehrlichia chaffeensis reside in different cytoplasmic compartments in HL-60 cells. Infect. Immun. 67:1368-1378.

    35. Olakanmi, O., L. S. Schlesinger, A. Ahmed, and B. E. Britigan. 2002. Intraphagosomal Mycobacterium tuberculosis acquires iron from both extracellular transferrin and intracellular iron pools. Impact of interferon-gamma and hemochromatosis. J. Biol. Chem. 277:49727-49734.

    36. Orino, K., L. Lehman, Y. Tsuji, H. Ayaki, S. V. Torti, and F. M. Torti. 2001. Ferritin and the response to oxidative stress. Biochem. J. 357:241-247.

    37. Payne, S. M. 1993. Iron acquisition in microbial pathogenesis. Trends Microbiol. 1:66-69.

    38. Pedra, J. H., B. Sukumaran, J. A. Carlyon, N. Berliner, and E. Fikrig. 2005. Modulation of NB4 promyelocytic leukemic cell machinery by Anaplasma phagocytophilum. Genomics 86:365-377.

    39. Pham, C. G., C. Bubici, F. Zazzeroni, S. Papa, J. Jones, K. Alvarez, S. Jayawardena, E. De Smaele, R. Cong, C. Beaumont, F. M. Torti, S. V. Torti, and G. Franzoso. 2004. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell 119:529-542.

    40. Picard, V., F. Renaudie, C. Porcher, M. W. Hentze, B. Grandchamp, and C. Beaumont. 1996. Overexpression of the ferritin H subunit in cultured erythroid cells changes the intracellular iron distribution. Blood 87:2057-2064.

    41. Posey, J. E., and F. C. Gherardini. 2000. Lack of a role for iron in the Lyme disease pathogen. Science 288:1651-1653.

    42. Ratledge, C., and L. G. Dover. 2000. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 54:881-941.

    43. Riemer, J., H. H. Hoepken, H. Czerwinska, S. R. Robinson, and R. Dringen. 2004. Colorimetric ferrozine-based assay for the quantitation of iron in cultured cells. Anal. Biochem. 331:370-375.

    44. Scaccabarozzi, A., P. Arosio, G. Weiss, L. Valenti, P. Dongiovanni, A. L. Fracanzani, M. Mattioli, S. Levi, G. Fiorelli, and S. Fargion. 2000. Relationship between TNF-alpha and iron metabolism in differentiating human monocytic THP-1 cells. Br. J. Haematol. 110:978-984.

    45. Schaible, U. E., and S. H. Kaufmann. 2004. Iron and microbial infection. Nat. Rev. Microbiol. 2:946-953.

    46. Stendahl, O., T. Andersson, C. Dahlgren, and K. E. Magnusson. 1986. Defective chemiluminescence response in differentiated HL60 cells due to impaired degranulation. Biochim. Biophys. Acta 881:430-436.

    47. Torti, F. M., and S. V. Torti. 2002. Regulation of ferritin genes and protein. Blood 99:3505-3516.

    48. Tsuji, Y., H. Ayaki, S. P. Whitman, C. S. Morrow, S. V. Torti, and F. M. Torti. 2000. Coordinate transcriptional and translational regulation of ferritin in response to oxidative stress. Mol. Cell. Biol. 20:5818-5827.

    49. Weinberg, E. D. 1989. Cellular regulation of iron assimilation. Q. Rev. Biol. 64:261-290.

    50. Yuan, X., Y. Cong, J. Hao, Y. Shan, Z. Zhao, S. Wang, and J. Chen. 2004. Regulation of LIP level and ROS formation through interaction of H-ferritin with G-CSF receptor. J. Mol. Biol. 339:131-144.(Jason A. Carlyon, Dara Ry)